Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
CRRTF:USOTC US

Crescita Therapeutics Inc

COMPANY INFO
0.65USD
-0.04-5.91%
Market Closed
As of 08/16/2019 EDT
Open
0.65
Prev Close
0.69
Volume
850
Market Cap
13.578M
Day Range
0.650.65
52 Week Range
0.300.91
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/16/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio3.12
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding21.02M
Price to Book Ratio0.8339
Price to Sales Ratio0.7451
1 Year Return90.09%
30 Day Avg Volume5,086
EPS--
Bloomberg (BEst) EPS Curr Yr--
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending Q3/2019:11/08/2019

Compare
1-Day Performance

-7%0+2%
-7%0+2%
Equity
CRRTF:US
-5.91%
Sponsored By

About Crescita Therapeutics Inc

Crescita Therapeutics Inc. operates as a biotechnology company. The Company owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Crescita Therapeutics conducts its operations in North America.
Address
7560 Airport Road Unit 10 Mississauga, ON L4T 4H4 Canada
Phone
1-905-673-4295
Website
www.crescitatherapeutics.com

Income Statement

Quarterly
Annual
;
Q2 2019 (Millions CAD)
  • Revenue
    9.36
  • Net Income
    2.21
  • Profit Margin
    23.58%

Balance Sheet

Quarterly
Annual
;
Q2 2019 (Millions CAD)
  • Total Assets
    31.53
  • Total Liabilities
    9.86
  • Debt to Assets
    16.62%

Cash Flow

Quarterly
Annual
Q2 2019 (Millions CAD)
  • Operating
    1.22
  • Investing
    -0.08
  • Financing
    -0.33